Unlock stock picks and a broker-level newsfeed that powers Wall Street.

3 High-Yield Dividend Stocks Offering Up To 6.2%

In This Article:

As global markets navigate a mixed landscape, with U.S. stocks closing out a strong year despite recent volatility and European inflationary pressures influencing economic sentiment, investors are increasingly seeking stability through dividend stocks. In such an environment, high-yield dividend stocks can offer attractive income potential while providing some cushion against market fluctuations.

Top 10 Dividend Stocks

Name

Dividend Yield

Dividend Rating

Peoples Bancorp (NasdaqGS:PEBO)

5.13%

★★★★★★

Financial Institutions (NasdaqGS:FISI)

4.57%

★★★★★★

Guaranty Trust Holding (NGSE:GTCO)

6.49%

★★★★★★

Southside Bancshares (NYSE:SBSI)

4.68%

★★★★★★

Padma Oil (DSE:PADMAOIL)

7.51%

★★★★★★

GakkyushaLtd (TSE:9769)

4.39%

★★★★★★

Premier Financial (NasdaqGS:PFC)

5.02%

★★★★★★

Citizens & Northern (NasdaqCM:CZNC)

6.01%

★★★★★★

DoshishaLtd (TSE:7483)

3.79%

★★★★★★

Banque Cantonale Vaudoise (SWX:BCVN)

5.01%

★★★★★★

Click here to see the full list of 2019 stocks from our Top Dividend Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Industrial and Commercial Bank of China

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Industrial and Commercial Bank of China Limited, along with its subsidiaries, offers a range of banking products and services both in the People's Republic of China and internationally, with a market cap of HK$2.36 trillion.

Operations: Industrial and Commercial Bank of China Limited generates revenue through various segments, including corporate banking, personal banking, treasury operations, and others.

Dividend Yield: 6.2%

Industrial and Commercial Bank of China offers a stable dividend profile, with dividends reliably increasing over the past decade. The current payout ratio of 45.9% suggests sustainability, and future forecasts indicate further coverage improvement to 30.7%. Despite a lower yield (6.24%) compared to top-tier Hong Kong dividend payers (8.05%), it remains attractive due to its consistent performance and earnings growth of 3.7% annually over five years, complemented by recent board approvals for continued profit distribution plans.

SEHK:1398 Dividend History as at Jan 2025
SEHK:1398 Dividend History as at Jan 2025

Hubei Jumpcan Pharmaceutical

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Hubei Jumpcan Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and trading of both Chinese traditional and western medicines as well as health products in China, with a market cap of approximately CN¥26 billion.